Lane Labs ordered to refund money
The FDA has ordered a refund program be established, following a federal district court ruling that Lane Labs USA marketed three products as treatments for cancer, HIV, and skin cancer without FDA approval. Consumers who purchased BeneFin, MGN-3, and SkinAnswer between Sept. 22, 1999, and July 12, 2004, are eligible for a partial refund of the purchase price and any shipping and handling costs.
Lane Labs ordered to refund money
The FDA has ordered a refund program be established, following a federal district court ruling that Lane Labs USA marketed three products as treatments for cancer, HIV, and skin cancer without FDA approval. Consumers who purchased BeneFin, MGN-3, and SkinAnswer between Sept. 22, 1999, and July 12, 2004, are eligible for a partial refund of the purchase price and any shipping and handling costs. A copy of the claim form can be obtained at http://www.gilardi.com/lanelabs/.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
